TITLE

Is gastric cancer part of the tumour spectrum of hereditary non-polyposis colorectal cancer? A molecular genetic study

AUTHOR(S)
Gylling, A.; Abdel-Rahman, W. M.; Juhola, M.; Nuorva, K.; Hautala, E.; Järvinen, H. J.; Mecklin, J.-P.; Aarnio, M.; Peltomäki, P.
PUB. DATE
July 2007
SOURCE
Gut;Jul2007, Vol. 56 Issue 7, p926
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: Gastric cancer is the second most common extracolonic malignancy in individuals with hereditary non-polyposis colorectal cancer (HNPCC)/Lynch syndrome. As gastric cancer is relatively common in the general population as well, it is not clear whether or not gastric cancer is a true HNPCC spectrum malignancy. Aim: To determine whether or not gastric cancer is a true HNPCC spectrum malignancy. Subjects and methods: The molecular and clinicopathological profiles of gastric cancers (n = 13) from HNPCC mutation carriers were evaluated and compared with the profiles of sporadic gastric cancers (n = 46) stratified by histology and microsatellite instability (MSI) status. Results: This study on sporadic and HNPCC gastric cancers revealed several important universal associations. Loss of heterozygosity in the adenomatous polyposis coli (APC) region was associated with intestinal histology regardless of the MSI (p=0.007). KRAS-mutations (p=0.019) and frameshift mutations in repeat tracts of growth-regulatory genes (p<0.001) were associated with MSI tumours being absent in microsatellite stable (MSS) tumours. The average number of methylated tumour suppressor gene loci among the 24 genes studied (methylation index) was higher in MSI than in MSS tumours regardless of histology (p<0.001). Gastric cancers from HNPCC mutation carriers resembled sporadic intestinal MSI gastric cancers, except that MLH1 promoter methylation was absent (p<0.001) and the general methylation index was lower (p=0.038), suggesting similar, but not identical, developmental pathways. All these lacked the mismatch repair protein corresponding to the germline mutation and displayed high MSI. Conclusion: The present molecular evidence, combined with the previous demonstration of an increased incidence relative to the general population, justify considering gastric cancers as true HNPCC spectrum malignancies.
ACCESSION #
25602397

 

Related Articles

  • Convergence of Mutation and Epigenetic Alterations Identifies Common Genes in Cancer That Predict for Poor Prognosis. Chan, Timothy A.; Glockner, Sabine; Yi, Joo Mi; Chen, Wei; Neste, Leander Van; Cope, Leslie; Herman, James G.; Velculescu, Victor; Schuebel, Kornel E.; Ahuja, Nita; Baylin, Stephen B. // PLoS Medicine;May2008, Vol. 5 Issue 5, pe114 

    Stephen Baylin and colleagues show that a combined genetic and epigenetic analysis of breast and colon cancers identifies a number of clinically significant genes targeted by multiple modes of inactivation.

  • Mutations and polymorphisms in TP53 gene—an overview on the role in colorectal cancer. Naccarati, A.; Polakova, V.; Pardini, B.; Vodickova, L.; Hemminki, K.; Kumar, R.; Vodicka, P. // Mutagenesis;Mar2012, Vol. 27 Issue 2, p211 

    A functionally normal TP53 is essential to protect organisms from developing cancer. Somatic mutations in the gene represent one of the highest recurring perturbations in human tumours, including colorectal cancer (CRC). However, the variegated phenotype of wide spectrum of somatic mutations in...

  • Mutations in the ST7/RAY1/HELG locus rarely occur in primary colorectal, gastric, and hepatocellular carcinomas. Yoshimura, S; Yamada, T; Ohwada, S; Koyama, T; Hamada, K; Tago, K; Sakamoto, I; Takeyoshi, I; Ikeya, T; Makita, F; Iino, Y; Morishita, Y // British Journal of Cancer;6/16/2003, Vol. 88 Issue 12, p1909 

    Human cancers frequently show a loss of heterozygosity on chromosome 7q31, which indicates the existence of broad-range tumour-suppressor gene(s) at this locus. Truncating mutations in the ST7 gene at this locus are seen frequently in primary colon cancer and breast cancer cell lines. Therefore,...

  • NIPBL, a Cohesion Loading Factor, Is Somatically Mutated in Gastric and Colorectal Cancers with High Microsatellite Instability. Kim, Min; An, Chang; Chung, Yeun; Yoo, Nam; Lee, Sug // Digestive Diseases & Sciences;Nov2013, Vol. 58 Issue 11, p3376 

    No abstract available.

  • Tobacco, alcohol, and p53 overexpression in early colorectal neoplasia. Terry, Mary Beth; Neugut, Alfred I.; Mansukhani, Mahesh; Waye, Jerome; Harpaz, Noam; Hibshoosh, Hanina // BMC Cancer;2003, Vol. 3, p1 

    Background: The p53 tumor suppressor gene is commonly mutated in colorectal cancer. While the effect of p53 mutations on colorectal cancer prognosis has been heavily studied, less is known about how epidemiologic risk factors relate to p53 status, particularly in early colorectal neoplasia prior...

  • Alterations in PTEN and PIK3CA in colorectal cancers in the EPIC Norfolk study: associations with clinicopathological and dietary factors. Naguib, Adam; Cooke, James C.; Happerfield, Lisa; Kerr, Lucy; Gay, Laura J.; Luben, Robert N.; Ball, Richard Y.; Mitrou, Panagiota N.; McTaggart, Alison; Arends, Mark J. // BMC Cancer;2011, Vol. 11 Issue 1, p123 

    Background: The PTEN tumour suppressor gene and PIK3CA proto-oncogene encode proteins which contribute to regulation and propagation of signal transduction through the PI3K/AKT signalling pathway. This study investigates the prevalence of loss of PTEN expression and mutations in both PTEN and...

  • Stan Walker's CANCER SHOCK.  // Woman's Day (Australia Edition);12/21/2009, Vol. 61 Issue 51, p27 

    The article reports that Stan Walker, winner of the reality television series "Australian Idol," is a member of an extended family who for generations were plagued by hereditary stomach cancer. According to a research by Otago University scientists, a mutant cancer gene is responsible for the...

  • Hereditary breast cancer: from molecular pathology to tailored therapies. Tan, D. S. P.; Marchiò, C.; Reis-Filho, J. S. // Journal of Clinical Pathology;Oct2008, Vol. 61 Issue 10, p1073 

    Hereditary breast cancer accounts for up to 5-10% of all breast carcinomas. Recent studies have demonstrated that mutations in two high-penetrance genes, namely BRCA1 and BRCA2, are responsible for about 16% of the familial risk of breast cancer. Even though subsequent studies have failed to...

  • Murine models of colorectal cancer. Uronis, Joshua M.; Threadgill, David W. // Mammalian Genome;May2009, Vol. 20 Issue 5, p261 

    Colorectal cancer is one of the most prevalent cancers of humans. To experimentally investigate this common disease, numerous murine models have been established. These models accurately recapitulate the molecular and pathologic characteristics of human colorectal cancers, including activation...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics